Oncology and complications

  • Giuseppe Giordano Unit of Diagnostic and Interventional Radiology, ARNAS “Garibaldi-Nesima”, Catania, Italy.
  • Evangelia Kyriazi Endocrinology Department, General Hospital of Athens “G. Gennimatas”, Athens, Greece.
  • Charalampos Mavridis Department of Urology, University General Hospital of Heraklion, University of Crete, Medical School, Heraklion, Crete, Greece.
  • Francesco Persico Humanitas Clinical and Research Center - IRCCS, Department of Urology, Rozzano, Milan; University of Naples Federico II, Department of Neurosciences, Sciences of Reproduction, and Odontostomatology, Naples, Italy.
  • Charalampos Fragkoulis Urology Department, General Hospital of Athens “G. Gennimatas”, Athens, Greece.
  • Piergiorgio Gatto Ospedale di Sestri Levante - ASL 4 Liguria, Dipartimento Medico ad Elevata Integrazione Territoriale, Sestri Levante, Italy.
  • George Georgiadis Department of Urology, University General Hospital of Heraklion, University of Crete, Medical School, Heraklion, Crete, Greece.
  • Irene Giagourta Endocrinology Department, General Hospital of Athens “G. Gennimatas”, Athens, Greece.
  • Ioannis Glykas Urology Department, General Hospital of Athens “G. Gennimatas”, Athens, Greece.
  • Rodolfo Hurle Humanitas Clinical and Research Center - IRCCS, Department of Urology, Rozzano, Milan, Italy.
  • Massimo Lazzeri Humanitas Clinical and Research Center - IRCCS, Department of Urology, Rozzano, Milan, Italy.
  • Giovanni Lughezzani Humanitas Clinical and Research Center - IRCCS, Department of Urology, Rozzano, Milan; Humanitas University, Department of Biomedical Sciences, Rozzano, Milan, Italy.
  • Vincenzo Magnano San Lio Unit of Diagnostic and Interventional Radiology, ARNAS “Garibaldi-Nesima”, Catania, Italy.
  • Charalampos Mamoulakis Department of Urology, University General Hospital of Heraklion, University of Crete, Medical School, Heraklion, Crete, Greece.
  • Diego Meo Unit of Diagnostic and Interventional Radiology, ARNAS “Garibaldi-Nesima”, Catania, Italy.
  • Helen A. Papadaki Department of Hematology, University General Hospital of Heraklion, University of Crete, Medical School, Heraklion, Crete, Greece.
  • George Piaditis Endocrinology Department, General Hospital of Athens “G. Gennimatas”, Athens, Greece.
  • Charalampos Pontikoglou Department of Hematology, University General Hospital of Heraklion, University of Crete, Medical School, Heraklion, Crete, Greece.
  • Georgios Stathouros Urology Department, General Hospital of Athens “G. Gennimatas”, Athens, Greece.

Abstract

This collection of cases describes some unusual urological tumors and complications related to urological tumors and their treatment.

Case 1: A case of uretero-arterial fistula in a patient with long-term ureteral stenting for ureteral oncological stricture and a second case associated to retroperitoneal fibrosis were described. Abdominal CT, pyelography, cystoscopy were useful to show the origin of the bleeding. Angiography is useful for confirming the diagnosis and for subsequent positioning of an endovascular prosthesis which represents a safe approach with reduced post-procedural complications.

Case 2: A case of patient who suffered from interstitial pneumonitis during a cycle of intravesical BCG instillations for urothelial cancer. The patient was hospitalized for more than two weeks in a COVID ward for a suspected of COVID-19 pneumonia, but he did not show any evidence of SARS-CoV-2 infection during his hospital stay.

Case 3: A case of a young man with a functional urinary bladder paraganglioma who was successfully managed with complete removal of the tumor, leaving the urinary bladder intact.

Case 4: A case of a 61 year old male suffering from muscle invasive bladder cancer who was admitted for a radical cystectomy and on the eighth postoperative day developed microangiopathic hemolytic anemia and thrombocytopenia, which clinically defines thrombotic microangiopathy.

Dimensions

Altmetric

PlumX Metrics

Downloads

Download data is not yet available.

References

Moschowitz A. Simultaneous ligation of both external iliac arteries for secondary hemorrhage following bilateral ureterolithotomy. Ann Surg. 1908; 48:872-5. DOI: https://doi.org/10.1097/00000658-190812000-00009

Van den Bergh RC, Moll FL, de Vries JP, et al. Arterioureteral fistulas: unusual suspects systematic review of 139 cases. Urology. 2009; 74:251-5. DOI: https://doi.org/10.1016/j.urology.2008.12.011

Krambeck AE, DiMarco DS, Gettman MT, et al. Ureteroiliac artery fistula: diagnosis and treatment algorithm. Urology. 2005;66:990-4. DOI: https://doi.org/10.1016/j.urology.2005.05.036

Fox JA, Krambeck A, McPhail EF, et al. Ureteroarterial fistula treatment with open surgery versus endovascular management: long-term outcomes. J Urol. 2011; 185:945-50. DOI: https://doi.org/10.1016/j.juro.2010.10.062

Arts RJW, et al. BCG Vaccination Protects against Experimental Viral Infection in Humans through the Induction of Cytokines Associated with Trained Immunity. Cell Host Microbe. 2018; 23:89-100.e5. DOI: https://doi.org/10.1016/j.chom.2017.12.010

Malmstrom PU, et al. An individual patient data meta-analysis of the long-term outcome of randomised studies comparing intravesical mitomycin C versus bacillus Calmette-Guerin for nonmuscleinvasive bladder cancer. Eur Urol. 2009; 56:247. DOI: https://doi.org/10.1016/j.eururo.2009.04.038

Redelman-Sidi G, Glickman MS, Bochner BH. The mechanism of action of BCG therapy for bladder cancer-a current perspective. Nat Rev Urol. 2014; 11:153-162. DOI: https://doi.org/10.1038/nrurol.2014.15

Leestma JE, Price EB Jr. Paraganglioma of the urinary bladder. Cancer. 1971; 28:1063-73. DOI: https://doi.org/10.1002/1097-0142(1971)28:4<1063::AID-CNCR2820280433>3.0.CO;2-R

Al-Zahrani AA. Recurrent urinary bladder paraganglioma. Adv Urol. 2010; 2010:912125. DOI: https://doi.org/10.1155/2010/912125

Peng C, Bu S, Xiong S, et al. Non-functioning paraganglioma occurring in the urinary bladder: A case report and review of the literature. Oncol Lett. 2015; 10: 321-324. DOI: https://doi.org/10.3892/ol.2015.3222

Lenders JW, Duh QY, Eisenhofer G, et al. Endocrine Society. Pheochromocytoma and paraganglioma: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2014; 99:1915-42. DOI: https://doi.org/10.1210/jc.2014-1498

Eskazan AE, Buyuktas D, Soysal T. Postoperative thrombotic thrombocytopenic purpura. Surg Today. 2015; 45:8-16. DOI: https://doi.org/10.1007/s00595-013-0823-y

Scully M, Goodship T. How I treat thrombotic thrombocytopenic purpura and atypical haemolytic uraemic syndrome. Br J Haematol. 2014; 164:759-66. DOI: https://doi.org/10.1111/bjh.12718

Published
2021-03-19
Info
Issue
Section
Case Collection
Keywords:
Ureter-arterial fistula; BCG; Pneumonitis; Bladder tumors; Cystectomy; Paraganglioma; Thrombotic thrombocytopenic purpura
Statistics
  • Abstract views: 241

  • PDF: 174
How to Cite
Giordano, G., Kyriazi, E., Mavridis, C., Persico, F., Fragkoulis, C., Gatto, P., Georgiadis, G., Giagourta, I., Glykas, I., Hurle, R., Lazzeri, M., Lughezzani, G., Magnano San Lio, V., Mamoulakis, C., Meo , D., Papadaki, H. A., Piaditis, G., Pontikoglou, C., & Stathouros, G. (2021). Oncology and complications. Archivio Italiano Di Urologia E Andrologia, 93(1), 71-76. https://doi.org/10.4081/aiua.2021.1.71

Most read articles by the same author(s)